Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report-Reference-Cited by-同舟云学术

Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report

Published:2022-08-29 Issue: Volume: Page:
ISSN:0975-7651
Container-title:Indian Journal of Surgical Oncology
language:en
Short-container-title:Indian J Surg Oncol

Author:

Huang Fay^ORCID,Shamavonian Raphael,Morris David L.

Abstract

AbstractGallbladder cancer is a rare cancer, associated with an extremely poor prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is not commonly performed in gallbladder cancer; however, case series have shown prolonged survival time with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gallbladder cancer and no increase in morbidity compared to cytoreductive surgery without hyperthermic intraperitoneal chemotherapy. We present a case of gallbladder cancer with peritoneal metastases in a 60-year-old male who was successfully treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and survived for 4 years following diagnosis.

Funder

University of New South Wales

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s13193-022-01634-3.pdf

Reference16 articles.

1. Tange S, Hakuta R, Nakai Y, Oyama H, Noguchi K, Ito Y, Bae Y, Kumasaka T, Yoshida H (2021) A rare case of gallbladder cancer with multiple metastases to the colon. Clin J Gastroenterol 14:608–612. https://doi.org/10.1007/s12328-020-01301-6

2. Surveillance Research Program, National Cancer Institute, SEER*Explorer: an interactive website for SEER cancer statistics [Internet] (2021). https://seer.cancer.gov/explorer/. Accessed 12 Apr 2022

3. G Choi, S Jang, M Choi, S Yang, C Lee, CM Kang (2022) Curative intent radical cholecystectomy followed by hyperthermic intraperitoneal chemotherapy in ruptured intraductal papillary neoplasm of gallbladder with invasive carcinoma. Ann Hepato-Biliary-Pancreatic Surg 26: 113–117. https://doi.org/10.14701/ahbps.21-071

4. Goéré D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, Glehen O (2017) Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). Int J Hyperth 33:520–527. https://doi.org/10.1080/02656736.2017.1301576

5. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer 116:5608–5618. https://doi.org/10.1002/cncr.25356

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very Rare Peritoneal Surface Malignancies;Indian Journal of Surgical Oncology;2023-01-24